approval with PIC/S accreditation from Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) for its pre-filled syringe facility in Baddi, India. The certification, announced on November 5 ...

Venus Remedies Ltd stated on Tuesday that the National Pharmaceutical Regulatory ... granted approval for the company’s robotic Pre-Filled Syringe (PFS) plant at its Baddi location.

To estimate the sizes and growth rates of the syringe market and its various subsegments, a blend of bottom-up and top-down analytical methods was employed. All percentage shares, splits ...

accreditation from the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia for its state-of-the-art robotic pre-filled syringe (PFS) facility at its Baddi unit. This marks the first PIC/S GMP ...

The differences between PFSs and MDVs (per 1000 doses) is 324.21. MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe. Prefilled syringes (PFSs) have gained market share in the USA ...

Shares of Hikma Pharmaceuticals PLC HIK slipped 2.64% to £17.72 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the FTSE 100 Index UKX falling 0.07% ...

Hikma Pharmaceuticals PLC HIK shares shed 1.94% to £18.20 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 0.14% to ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. Riad Mishlawi, Hikma’s CEO, said: “I am pleased ...

SMi is delighted to announce its 4 th annual Pre-Filled Syringes West Coast conference coming to San Diego, USA on the 3 rd and 4 th June 2019. The competitive PFS market has sparked great ...

On Thursday, West Pharmaceutical Services, Inc. (NYSE:WST) reported adjusted EPS of $1.85, down from $2.16 a year ago, beating the consensus of $1.50. The designer and manufacturer of injectable ...